Cite
HARVARD Citation
Longo de Oliveira, A. et al. (2022). Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial. Clinical and applied thrombosis/hemostasis. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Longo de Oliveira, A. et al. (2022). Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial. Clinical and applied thrombosis/hemostasis. p. . [Online].